Tag: Medicare Part B biosimilars
Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
Biosimilars are billed using unique HCPCS codes and reimbursed at 100% of their ASP plus 6% of the brand-name drug’s price. This system creates a financial disincentive for providers to switch, slowing adoption despite lower drug costs.
